Leaving the study early · Adults with PTSD for at least 3 months
It is very uncertain whether trauma‐focused CBT/Exposure therapy changes leaving the study early for any reason compared with waitlist/Usual Care (very low certainty).
1 finding from 1 review
Leaving the study early · Adults with PTSD for at least 3 months
1 finding from 1 review
Leaving the study early · Adults with PTSD for at least 3 months
It is very uncertain whether other therapies changes leaving the study early due to any reason compared with waitlist/Usual Care (very low certainty).
1 finding from 1 review
Leaving the study early · Adults with PTSD for at least 3 months
1 finding from 1 review
Leaving the study early · Adults with PTSD for at least 3 months
It is very uncertain whether trauma‐focused CBT/Exposure therapy changes leaving the study early for any reason compared with non‐TFCBT (very low certainty).
1 finding from 1 review
Leaving the study early · Adults with PTSD for at least 3 months
It is very uncertain whether trauma‐focused CBT/Exposure therapy changes leaving the study early for any reason compared with other therapies (very low certainty).
1 finding from 1 review
Leaving the study early · Adults with PTSD for at least 3 months
It is very uncertain whether EMDR changes leaving study early for any reason compared with waitlist/Usual Care (very low certainty).
1 finding from 1 review
Leaving the study early/ loss to · patients with schizophrenia
It is very uncertain whether INTERMITTENT (CRISIS INTERVENTION) changes leaving the study early/ loss to compared with MAINTENANCE THERAPY (very low certainty).
1 finding from 1 review
Leaving the study early/ loss to · patients with schizophrenia
It is very uncertain whether INTERMITTENT (GRADUALLY INCREASED DRUG‐FREE PERIODS) changes leaving the study early/ loss to compared with MAINTENANCE THERAPY (very low certainty).
1 finding from 1 review
Leaving the study early/ loss to · patients with schizophrenia
It is very uncertain whether INTERMITTENT (DRUG HOLIDAY) changes leaving the study early/ loss to compared with MAINTENANCE THERAPY (very low certainty).
2 findings from 1 review
Leaving the study early/ loss to · patients with schizophrenia
It is very uncertain whether ANY INTERMITTENT DRUG TECHNIQUE changes leaving the study early/ loss to compared with PLACEBO (very low certainty).
1 finding from 1 review
Clinical global response‐leaving the study early (short term) · patients with schizophrenia
DANCE THERAPY showed no clear difference in clinical global response‐leaving the study early (short term) compared with STANDARD CARE (moderate certainty).
1 finding from 1 review
Clinical global response‐leaving the study early (long term) · patients with schizophrenia
DANCE THERAPY showed no clear difference in clinical global response‐leaving the study early (long term) compared with STANDARD CARE (low certainty).
1 finding from 1 review
Adverse events Adverse events includes withdrawal and drop‐outs that could be clearly identified as due to an adverse event · patients with fibromyalgia
Acupuncture showed no clear difference in adverse events Adverse events includes withdrawal and drop‐outs that… compared with placebo or sham acupuncture (moderate certainty).
1 finding from 1 review
Leaving the study early · patients with schizophrenia
Quetiapine showed no clear difference in leaving the study early due to any reason compared with typical antipsychotics (moderate certainty).
1 finding from 1 review
Leaving the study early because of weight gain (risperidone vs olanzapine) · people with psychosis
1 finding from 1 review
Adverse effects: Leaving the study early · people with psychosis
1 finding from 1 review
Leaving the study early · patients with chronic mental illnesses
It is very uncertain whether life skills programme changes leaving the study early compared with standard care (very low certainty).
1 finding from 1 review
Leaving the study early · patients with sexual dysfunction due to antipsychotic drug therapy
It is very uncertain whether SWITCHING ANTIPSYCHOTIC: TO QUETIAPINE changes leaving the study early compared with MAINTENANCE RISPERIDONE (very low certainty).
1 finding from 1 review
Leaving the study early · patients with sexual dysfunction due to antipsychotic drug therapy
It is very uncertain whether SWITCHING ANTIPSYCHOTIC: TO OLANZAPINE changes leaving the study early compared with MAINTENANCE RISPERIDONE/FGA (very low certainty).
1 finding from 1 review